What is PLUVICTO? PLUVICTO is a radiopharmaceutical used to treat adults with an advanced cancer called prostate-specific membrane antigen–positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC) that:
- has spread to other parts of the body (metastatic), and
- has already been treated with other anticancer treatments
How does PLUVICTO Work?
- PSMA is a biomarker that is expressed on prostate cancer cells and can be seen on a PSMA PET scan.
- PLUVICTO is used to target PSMA-positive cancer cells.
- Once PLUVICTO attaches to PSMA, it is absorbed by the cell.
- Once PLUVICTO is absorbed by the cell, it releases radiation that kill cells that are PSMA+
- PLUVICTO Is not Chemotherapy
PLUVICTO assists with tumor reduction and has helped increase overall survival rate for patients with this specific type of prostate cancer.
Our Advanced Cancer Nuclear Oncology Team comprised of Dr. Josh Weir and Dr. Ellen Cooke utilizes state of the art technologies in personalized nuclear medicine treatments for our patients.
Dr. Josh Weir is experienced in administering PLUVICTO to our PSMA+ patients, as we have completed our first patient series in the past month. Utilizing cutting edge treatments to target specific cancer cells is the future of cancer care.
Dr. Tim Richardson, our prostate cancer specialist believes that “PLUVICTO offers patients with PSMAC+ the most advanced targeted cancer treatment available to patients in the South-Central Kansas and surrounding area.”
PLUVICTO is the first and only approved PSMA-targeted radioligand therapy
 | PSMA is a biomarker that is expressed on prostate cancer cells and can be seen on a PSMA PET Scan. PLUVICTO can be used to target PSMA-positive cancer cells. | |
| Once PLUVICTO attaches to PSMA, it is absorbed by the cell. |  | |
 | Once PLUVICTO is absorbed by the cell, it releases radiation that can damage and kill cells that are PSMA+ and other nearby cells. |
For more information:
https://us.pluvicto.com/about-pluvicto/how-pluvicto-works
https://us.pluvicto.com/patient-support/video-library
Images and patient education courtesy of Novartis